✦ LIBER ✦

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials)

✍ Scribed by Larisa Rudenko; Julia Desheva; Sergey Korovkin; Alexander Mironov; Andrey Rekstin; Elena Grigorieva; Svetlana Donina; Alexandra Gambaryan; Anton Katlinsky

Book ID: 111403548
Publisher: Wiley (Blackwell Publishing)
Year: 2008
Tongue: English
Weight: 99 KB
Volume: 2
Category: Article
ISSN: 1750-2640
DOI: 10.1111/j.1750-2659.2008.00064.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, tolerability and immunogenicity

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: A sequential Phase I and Phase II clinical trial

✍ N. Groth; E. Montomoli; C. Gentile; I. Manini; R. Bugarini; A. Podda 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Phase 1 clinical trials of the safety an

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

✍ Larry R. Smith; Mary K. Wloch; Ming Ye; Luane R. Reyes; Souphaphone Boutsaboualo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Safety and Cross-Reactive Immunogenicity

Safety and Cross-Reactive Immunogenicity of Two H5N1 A/Indonesia/5/2005 (Clade 2.1) AS-Adjuvanted Prepandemic Candidate Influenza Vaccines: A Phase I/II Clinical Trial

✍ J. Langley; L. Frenette; L. Ferguson; D. Riff; S. Folkerth; E. Sheldon; N. Segal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

A live attenuated H7N3 influenza virus v

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

✍ Kawsar R. Talaat; Ruth A. Karron; Karen A. Callahan; Catherine J. Luke; Susan C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 331 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

✍ Jean-Louis Bresson; Christian Perronne; Odile Launay; Catherine Gerdil; Melanie 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 123 KB

Safety and immunogenicity of an inactiva

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

✍ Jiangtao Lin; Jiansan Zhang; Xiaoping Dong; Hanhua Fang; Jiangting Chen; Nan Su; 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 135 KB